Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
27 Results for "
Nucleotide pyrophosphatase/phosphodiesterase
" in MedChemExpress (MCE) Product Catalog:
Products (27)
27 Results for "Nucleotide pyrophosphatase/phosphodiesterase" in MCE Product Catalog:
3
3 Cited Publications
Target:
Research Areas:
Enpp-1-IN-1 is an effective selective enpp-1 (nucleotide pyrophosphatase-phosphodiesterase 1) inhibitor .
Target:
Research Areas:
Enpp-1-IN-12 (compound 43) is a potent and orally active ecto-nucleotide pyrophosphatase/phosphodiesterases 1 (ENPP1) inhibitor, with a Ki of 41 nM. Enpp-1-IN-12 exhibits anti-tumor activity .
Target:
Research Areas:
Enpp-1-IN-21 (compound 4g) is an inhibitor of ecto-nucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1), with IC50 values for ENPP1 and ENPP3 at 0.45 and 0.19 μM, respectively .
Target:
Research Areas:
Enpp-1-IN-10 (compound 1) is a potent Ecto-nucleotide pyrophosphatase/phosphodiesterases 1 (ENPP1) inhibitor with an Ki value of 3.866 μM. Enpp-1-IN-10 can be used for researching anticancer .
Cat. No.: HY-143255
CAS No.: 2631703-04-1
Target:
Research Areas:
Enpp-1-IN-11 (compound 23) is a potent Ecto-nucleotide pyrophosphatase/phosphodiesterases 1 (ENPP1) inhibitor with an Ki value of 45 nM. Enpp-1-IN-11 exhibits low clearance in human and mouse liver microsomes, good plasma stability in human and mouse plasma. Enpp-1-IN-11 can be used for researching anticancer .
Cat. No.: HY-145064
CAS No.: 2718971-29-8
Target:
Enpp-1-IN-6 is a potent inhibitor of ectonucleotide pyrophosphatase-phosphodiesterase 1 (enpp-1). The ENPP 1 has broad specificity and can cleave a variety of substrates, including phosphodiester bonds of nucleotides and nucleotide sugars and pyrophosphate bonds nucleotides and nucleotide sugars. Enpp-1-IN-6 has the potential for the research of cancer and infectious diseases (extracted from patent WO2021203772A1, compound 51) .
Cat. No.: HY-145065
Target:
Enpp-1-IN-7 is a potent inhibitor of ectonucleotide pyrophosphatase-phosphodiesterase 1 (enpp-1). The ENPP 1 has broad specificity and can cleave a variety of substrates, including phosphodiester bonds of nucleotides and nucleotide sugars and pyrophosphate bonds nucleotides and nucleotide sugars. Enpp-1-IN-7 has the potential for the research of cancer and infectious diseases (extracted from patent WO2021203772A1, compound 51) .
Cat. No.: HY-145069
CAS No.: 2718971-08-3
Target:
Research Areas:
Enpp-1-IN-8 is a potent inhibitor of ectonucleotide pyrophosphatase-phosphodiesterase 1 (enpp-1). The ENPP 1 has broad specificity and can cleave a variety of substrates, including phosphodiester bonds of nucleotides and nucleotide sugars and pyrophosphate bonds nucleotides and nucleotide sugars. Enpp-1-IN-8 has the potential for the research of cancer and infectious diseases (extracted from patent WO2021203772A1, compound 51) .
Cat. No.: HY-145070
CAS No.: 2718970-70-6
Target:
Enpp-1-IN-9 is a potent inhibitor of ectonucleotide pyrophosphatase-phosphodiesterase 1 (enpp-1). The ENPP 1 has broad specificity and can cleave a variety of substrates, including phosphodiester bonds of nucleotides and nucleotide sugars and pyrophosphate bonds nucleotides and nucleotide sugars. Enpp-1-IN-9 has the potential for the research of cancer and infectious diseases (extracted from patent WO2021203772A1, compound 51) .
Target:
Research Areas:
Enpp-1-IN-5 is a potent inhibitor of ectonucleotide pyrophosphatase-phosphodiesterase 1 (enpp-1). The ENPP 1 has broad specificity and can cleave a variety of substrates, including phosphodiester bonds of nucleotides and nucleotide sugars and pyrophosphate bonds nucleotides and nucleotide sugars. Enpp-1-IN-5 has the potential for the research of cancer and infectious diseases (extracted from patent WO2019046778A1/WO2021203772A1, compound 1) .
Cat. No.: HY-P700438
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: ENPP3; B10; Prev. PDNP3; NPPase; EctoNucleotide pyrophosphatase/phosphodiesterase Family Member 3; NPP3; phosphodiesterase I/Nucleotide pyrophosphatase 3; DJ334I18.1 (EctoNucleotide pyrophosphatase/phosphodiesterase 3); Alkaline phosphodiesterase I; DJ1005H11.3 (phosphodiesterase I/Nucleotide pyrophosphatase 3); Dinucleoside Polyphosphatase; DJ914N13.3 (phosphodiesterase I/Nucleotide pyrophosphatase 3); Nucleotide pyrophosphatase; phosphodiesterase-I Beta; Nucleotide Diphosphatase; CD203c Antigen; Gp130RB13-6; PD-Ibeta; PD-IBETA; E-NPP 3; CD203c; EctoNucleotide pyrophosphatase/phosphodiesterase 3; phosphodiesterase I Beta
Species:
Cynomolgus
Source:
HEK293
Cat. No.: HY-P810389
Synonyms: Alkaline phosphodiesterase I, ARHR2, B10, CD203c, CD203c antigen, dJ1005H11.3 (phosphodiesterase I/Nucleotide pyrophosphatase 3), dJ914N13.3 (phosphodiesterase I/Nucleotide pyrophosphatase 3), E NPP 3, E-NPP 3, EctoNucleotide pyrophosphatase/phosphodiesterase 3
Cat. No.: HY-P78705
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: ENPP3; B10; Prev. PDNP3; NPPase; EctoNucleotide pyrophosphatase/phosphodiesterase Family Member 3; NPP3; phosphodiesterase I/Nucleotide pyrophosphatase 3; DJ334I18.1 (EctoNucleotide pyrophosphatase/phosphodiesterase 3); Alkaline phosphodiesterase I; DJ100
Species:
Mouse
Source:
HEK293
Cat. No.: HY-P700410
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: ENPP3; B10; Prev. PDNP3; NPPase; EctoNucleotide pyrophosphatase/phosphodiesterase Family Member 3; NPP3; phosphodiesterase I/Nucleotide pyrophosphatase 3; DJ334I18.1 (EctoNucleotide pyrophosphatase/phosphodiesterase 3); Alkaline phosphodiesterase I; DJ100
Species:
Human
Source:
HEK293
Cat. No.: HY-P77357
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: ENPP3; B10; Prev. PDNP3; NPPase; EctoNucleotide pyrophosphatase/phosphodiesterase Family Member 3; NPP3; phosphodiesterase I/Nucleotide pyrophosphatase 3; DJ334I18.1 (EctoNucleotide pyrophosphatase/phosphodiesterase 3); Alkaline phosphodiesterase I; DJ100
Species:
Rhesus Macaque
Source:
Sf9 insect cells
Cat. No.: HY-P700710
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: ENPP3; B10; Prev. PDNP3; NPPase; EctoNucleotide pyrophosphatase/phosphodiesterase Family Member 3; NPP3; phosphodiesterase I/Nucleotide pyrophosphatase 3; DJ334I18.1 (EctoNucleotide pyrophosphatase/phosphodiesterase 3); Alkaline phosphodiesterase I; DJ100
Species:
Canine
Source:
HEK293
Cat. No.: HY-P704579
Purity: ≥ 95%, as determined by Bis-Tris PAGE.
Synonyms: ENPP3; B10; Prev. PDNP3; NPPase; EctoNucleotide pyrophosphatase/phosphodiesterase Family Member 3; NPP3; phosphodiesterase I/Nucleotide pyrophosphatase 3; DJ334I18.1 (EctoNucleotide pyrophosphatase/phosphodiesterase 3); Alkaline phosphodiesterase I; DJ100
Species:
Human
Source:
HEK293
Cat. No.: HY-P705017
Purity: ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: ENPP3; B10; Prev. PDNP3; NPPase; EctoNucleotide pyrophosphatase/phosphodiesterase Family Member 3; NPP3; phosphodiesterase I/Nucleotide pyrophosphatase 3; DJ334I18.1 (EctoNucleotide pyrophosphatase/phosphodiesterase 3); Alkaline phosphodiesterase I; DJ100
Species:
Human
Source:
CHO
Cat. No.: HY-P77925
Purity: ≥ 95%, as determined by Bis-Tris PAGE.
Synonyms: ENPP3; B10; Prev. PDNP3; NPPase; EctoNucleotide pyrophosphatase/phosphodiesterase Family Member 3; NPP3; phosphodiesterase I/Nucleotide pyrophosphatase 3; DJ334I18.1 (EctoNucleotide pyrophosphatase/phosphodiesterase 3); Alkaline phosphodiesterase I; DJ100
Species:
Human
Source:
HEK293
Cat. No.: HY-P77928
Purity: ≥ 95%, as determined by Bis-Tris PAGE.
Synonyms: ENPP3; B10; Prev. PDNP3; NPPase; EctoNucleotide pyrophosphatase/phosphodiesterase Family Member 3; NPP3; phosphodiesterase I/Nucleotide pyrophosphatase 3; DJ334I18.1 (EctoNucleotide pyrophosphatase/phosphodiesterase 3); Alkaline phosphodiesterase I; DJ100
Species:
Human
Source:
HEK293
- 1
- 2
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
